Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives

References

• AbuchowskiAVan EsTPalczukNC1977Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycolJ Biol Chem252357881405385
   PubMed Web of Science ®Google Scholar
• AbuchowskiAKazoGMVerhoestCR1984Cancer therapy with chemically modified enzymes. I. Antitumor properties of poly-ethylene glycol asparaginase conjugatesCancer Biochem Biophys7175866467175
   PubMedGoogle Scholar
• AcarHYGaraasRSSyudF2005Superparamagnetic nanoparticles stabilized by polimerized PEGylated coatingsJ Magnet Magnet Mater29317
   Web of Science ®Google Scholar
• AguRUUgwokeMIArmandM2001The lung as a route for systemic delivery of therapeutic proteins and peptidesRespir Res219820911686885
   PubMed Web of Science ®Google Scholar
• BangaAK2003Deivery of protein therapeuticsBusiness Briefing: Pharmatech198201
   Google Scholar
• Barbault-FoucherSGrefRRussoP2002Design of poly-ɛ-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular deliveryJ Control Rel8336575
   PubMed Web of Science ®Google Scholar
• BargoniACavalliRZaraGP2001Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II – Tissue distributionPharm Res43497502
   Web of Science ®Google Scholar
• BoccaCCaputoOCavalliR1998Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticlesInt J Pharm17518593
   Web of Science ®Google Scholar
• CastelliFPugliaCSarpietroMG2005Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetryInt J Pharm3042313816188405
   PubMed Web of Science ®Google Scholar
• CavalliRMorelSGascoMR1995Preparation and evaluation of colloidal lipospheres containing pilocarpine as ion pairInt J Pharm1172436
   Web of Science ®Google Scholar
• CavalliRCaputoOCarlottiME1997Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticlesInt J Pharm1484754
   Web of Science ®Google Scholar
• CavalliRPeiraECaputoO1999Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with β-cyclodextrinsInt J Pharm182596910332075
   PubMed Web of Science ®Google Scholar
• CavalliRGascoMRChetoniP2002Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycinInt J Pharm238241511996827
   PubMed Web of Science ®Google Scholar
• CharcossetCEl-HaratiAFessiH2005Preparation of solid lipid nanoparticles using a membrane contactorJ Control Release1081122016169111
   PubMed Web of Science ®Google Scholar
• ChenHChangXDuD2006Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targetingJ Control Release11029630616325954
   PubMed Web of Science ®Google Scholar
• CortesiREspositoELucaG2002Production of lipospheres as carriers for bioactive compoundsBiomaterials2322839412013175
   PubMed Web of Science ®Google Scholar
• DamgéCMichelCAprahamianM1990Nanocapsules as carriers for oral peptide deliveryJ Control Release132339
   Web of Science ®Google Scholar
• De CamposASánchezAAlonsoMJ2001Chitosan nanoparticles: a new vehicle for the improvement of the ocular retention of drugs. Application to cyclosporin AInt J Pharm2241596811472825
   PubMed Web of Science ®Google Scholar
• De CamposAMSánchezAGrefR2003The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosaEur J Pharm Sci20738113678795
   PubMed Web of Science ®Google Scholar
• De VringerTDe RondeHAG1995Preparation and structure of a water-in-oil cream containing lipid nanoparticlesJ Pharm Sci84466727629738
   PubMed Web of Science ®Google Scholar
• DemirelMYazanYMüllerRH2001Formulation and in vitro-in vivo evaluation of piribedil solid lipid micro- and nanoparticlesJ Microencapsul183597111308226
   PubMed Web of Science ®Google Scholar
• DierlingAMSloatBRCuiZ2006Gadolinium incorporated reconstituted chylomicron emulsion for potential application in tumor neutron capture therapyEur J Pharm Biopharm622758116274979
   PubMed Web of Science ®Google Scholar
• DinglerA1998Feste Lipid-nanopartikel als kolloidale Wirkstoffträgersysteme zur dermalen ApplikationPhD thesis,Freie Universität Berlin
   Google Scholar
• DinglerABlumRPNiehusH1999Solid lipid nanoparticles (SLN™/Lipopearls™) – a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal productsJ Microencapsul167516710575627
   PubMed Web of Science ®Google Scholar
• FreitasCMüllerRH1998Spray-drying of solid lipid nanoparticles (SLN™)Eur J Pharm Biopharm46145519795036
   PubMed Web of Science ®Google Scholar
• FriedrichIReichlSMüller-GoymannCC2005Drug release and permeation studies of nanosuspensions based on solidified reverse micellar solutions (SRMS)Int J Pharm3051677516242276
   PubMed Web of Science ®Google Scholar
• FundaroACavalliRBargoniA2000Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after iv administration to ratsPharm Res4233743
   Web of Science ®Google Scholar
• Garcia-FuentesMTorresDAlonsoMJ2002Design of lipid nanoparticles for the oral delivery of hydrophilic macromoleculesColl Surf B: Biointerf2715968
   Web of Science ®Google Scholar
• Garcia-FuentesMPregoCTorresD2005aA comparative study of the potential of solid glyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin deliveryEur J Pharm Sci251334315854809
   PubMed Web of Science ®Google Scholar
• Garcia-FuentesMTorresDAlonsoMJ2005bNew surface-modified lipid nanoparticles as delivery vehicles for salmon calcitoninInt J Pharm2961223215885464
   PubMed Web of Science ®Google Scholar
• Garcia-GarciaEAndrieuxKGilS2005A methodology to study intracellular distribution of nanoparticles in brain endothelial cellsInt J Pharm298310415923094
   PubMed Web of Science ®Google Scholar
• GascoMR1993Method for producing solid lipid microspheres having a narrow size distributionUS Patent 5 250 236.
   Google Scholar
• GohlaSHDinglerA2001Scaling up feasibility of the production of solid lipid nanoparticles (SLN™)Pharmazie5661311210672
   PubMed Web of Science ®Google Scholar
• GöppertTMMüllerRH2005Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targetingInt J Pharm3021728616098695
   PubMed Web of Science ®Google Scholar
• GrayBHStullRW1983Radioprotection by polyethylene glycol-protein complexes in miceRadiat Res9358176344128
   PubMed Web of Science ®Google Scholar
• GrefRDombAQuellecP1995The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheresAdv Drug Del Rev1621533
   PubMed Web of Science ®Google Scholar
• GrefRLückMQuellecP2000‘Stealth’ corona-core nanoparticle surface modified by polyethylene glycol (PEG): influence of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorptionColl Surf B: Biointerf1830113
   PubMed Web of Science ®Google Scholar
• Harivardhan ReddyLSharmaRKChuttaniK2005Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton’s lymphoma tumor bearing miceJ Control Release1051859815921775
   PubMed Web of Science ®Google Scholar
• HeiatiHTawashiRShiversRR1997Solid lipid nanoparticles as drug carriers I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitateInt J Pharm14612331
   Web of Science ®Google Scholar
• HeiatiHTawashiRPhillipsNC1998Solid lipid nanoparticles as drug carriers II. Plasma stability and biodistribution of solid lipid nanoparticles containing the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate in miceInt J Pharm1747180
   Web of Science ®Google Scholar
• HeurtaultBSaulnierPPechB2003Physico-chemical stability of colloidal lipid particlesBiomaterials24428330012853260
   PubMed Web of Science ®Google Scholar
• HouDZXieCSHuangK2003The production and characteristics of solid lipid nanoparticles (SLNs)Biomaterials2417818512593960
   PubMed Web of Science ®Google Scholar
• HuFQJiangSPDuYZ2005Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous systemColl Surf B: Biointerf4516773
   PubMed Web of Science ®Google Scholar
• IgartuaMSaulnierPHeurtaultB2002Development and characterization of solid lipid nanoparticles loaded with magnetiteInt J Pharm2331495711897419
   PubMed Web of Science ®Google Scholar
• IllumLDavisSSMüllerRH1987The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer poloxamine 908Life Sci40367703807638
   PubMed Web of Science ®Google Scholar
• JaniPUHalbertGWLangridgeJ1990Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependencyJ Pharm Pharmacol4282161983142
   PubMed Web of Science ®Google Scholar
• JenningVGyslerASchäfer-KortingM2000aVitamin A-loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skinEur J Pharm Biopharm49211810799811
   PubMed Web of Science ®Google Scholar
• JenningVMäderKGohlaSH2000bSolid lipid nanoparticles (SLN™) based on binary mixtures of liquid and solid lipids: a 1H-NMR studyInt J Pharm205152111000538
   PubMed Web of Science ®Google Scholar
• JoresKMehnertWDreschlerM2004Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopyJ Control Release95217714980770
   PubMed Web of Science ®Google Scholar
• KakizawaYKataokaK2002Block copolymer micelles for delivery of gene and related compoundsAdv Drug Deliv Rev54203211897146
   PubMed Web of Science ®Google Scholar
• KantoJ1975Plasma concentrations of diazepam and its metabolites after peroral, intramuscular and rectal administrationInt J Clin Pharmacol1241926
   Google Scholar
• KreuterJ2001Nanoparticulate systems for brain delivery of drugsAdv Drug Deliv Rev47658111251246
   PubMed Web of Science ®Google Scholar
• KržičMŠentjurcMKristlJ2001Improved skin oxygenation after benzyl nicotinate application in different carriers as measured by EPR oximetry in vivoJ Control Release702031111166420
   PubMed Web of Science ®Google Scholar
• LeeWAEnnisRDLongeneckerJP1994The bioavailability of intranasal salmon calcitonin in healthy volunteers with and without permeation enhancerPharm Res11747508058647
   PubMed Web of Science ®Google Scholar
• LiedtkeSWissingSAMüllerRH2000Inflence of high pressure homogenisation equipment on nanodispersions characteristicsInt J Pharm196183510699714
   PubMed Web of Science ®Google Scholar
• LippacherAMüllerRHMäderK2002Semisolid SLN™ dispersions for topical application: influence of formulation and production parameters on viscoelastic propertiesEur J Pharm Biopharm531556011879997
   PubMed Web of Science ®Google Scholar
• LudwigA2005The use of mucoadhesive polymers in ocular drug deliveryAdv Drug Del Rev571595639
   PubMed Web of Science ®Google Scholar
• LundbergBBMortimerBCRedgraveTG1996Submicron lipid emulsions containing amphipathic poly(ethylene glycol) for use as drug carriers with prolonged circulation timeInt J Pharm13411927
   Web of Science ®Google Scholar
• ManjunathKVenkateswarluV2005Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administrationJ Control Release1072152816014318
   PubMed Web of Science ®Google Scholar
• MehnertWMäderK2001Solid lipid nanoparticles. Production, characterization and applicationsAdv Drug Del Rev4716596
   PubMed Web of Science ®Google Scholar
• MeiZChenHWengT2003Solid lipid nanoparticle and microemulsion for topical delivery of triptolideEur J Pharm Biopharm561899612957632
   PubMed Web of Science ®Google Scholar
• MoghimiSHHawleyAEChristyNM1994Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the lymph nodesFEBS Lett34425308181558
   PubMed Web of Science ®Google Scholar
• MorelSTerrenoEUgazioE1998NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium (III) complexesEur J Pharm Biopharm45157639704912
   PubMed Web of Science ®Google Scholar
• MüllerRH1991Colloidal carriers for controlled drug delivery and targeting-modification, characterization and in vivo distributionWissenschaftliche Verlagsgesellschaft Stuttgart, CRC Press Boca Raton
   Google Scholar
• MüllerRHSchwarzCZur MühlenA1994Incorporation of lipo-philic drugs and drug release profiles of solid lipid nanoparticles (SLN)Proc Int Symp Control Rel Bioact Mater211467
   Google Scholar
• MüllerRHMehnertWLucksJS1995Solid lipid nanoparticles (SLN) – An alternative colloidal carrier system for controlled drug deliveryEur J Pharm Biopharm41629
   Web of Science ®Google Scholar
• MüllerRHMaaβenSWeyhersH1996aPhagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with Poloxamine 908 and Poloxamer 407J Drug Target416170
   PubMed Web of Science ®Google Scholar
• MüllerRHRühlDRungeS1996bBiodegradation of solid lipid nanoparticles as a function of lipase incubation timeInt J Pharm14411521
   Web of Science ®Google Scholar
• MüllerRHHildebrandGE1997Feste Lipidnanopartikel (SLN)MüllerRHPharmazeutische Technologie: Moderne ArzneiformenWissenschaftliche Verlagsgesellschaft Stuttgart26572
   Google Scholar
• MüllerRHRühlDLückM1997Influence of fluorescent labelling of polystyrene particles on phagocytic uptake, surface hydrophobicity, and plasma protein adsorptionPharm Res1418249034216
   PubMed Web of Science ®Google Scholar
• MüllerRHRungeSA1998Solid lipid nanoparticles (SLN®) for controlled drug deliveryBenitaSSubmicron emulsion in drug targeting and deliveryThe NetherlandsHarwood Academic Publishers21934
   Google Scholar
• MüllerRHMäderKGohlaS2000Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the artEur J Pharm Biopharm501617710840199
   PubMed Web of Science ®Google Scholar
• MüllerRHRadtkeMWissingSA2002aSolid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparationsAdv Drug Deliv Rev54Suppl. 1S13155
   PubMed Web of Science ®Google Scholar
• MüllerRHRadtkeMWissingSA2002bNanostructured lipid matrices for improved microencapsulation of drugsInt J Pharm2421218
   PubMed Web of Science ®Google Scholar
• MüllerRHKeckCM2004Challenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticlesJ Biotech11315170
   PubMed Web of Science ®Google Scholar
• MünsterUNakamuraCHaberlandA2005RU 58841-myristate – prodrug development for topical treatment of acne and androgenic alopeciaPharmazie6081215700772
   PubMed Web of Science ®Google Scholar
• OlbrichCBakowskiULehrCM2001Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNAJ Control Release773455511733101
   PubMed Web of Science ®Google Scholar
• OlbrichCKayserOMüllerRH2002Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN) – effect of surfactants, storage time and crystallinityInt J Pharm2371192811955810
   PubMed Web of Science ®Google Scholar
• OtsukaHNagasakiYKataokaK2003PEGylated nanoparticles for biological and pharmaceutical applicationsAdv Drug Deliv Rev554031912628324
   PubMed Web of Science ®Google Scholar
• OyewumiMOYokelRAJayM2004Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing miceJ Control Release956132615023471
   PubMed Web of Science ®Google Scholar
• PandeyRKhullerGK2005Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosisTuberculosis852273415922668
   PubMed Web of Science ®Google Scholar
• PandeyRSharmaSKhullerGK2005Oral solid lipid nanoparticle-based antitubercular chemotherapyTuberculosis854152016256437
   PubMed Web of Science ®Google Scholar
• PedersenNHansenSHeydenreichAV2006Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligandsEur J Pharm Biopharm621556216290122
   PubMed Web of Science ®Google Scholar
• PintoJFMüllerRH1999Pellets as carriers of solid lipid nanoparticles (SLN) for oral administration of drugsPharmazie545069
   Web of Science ®Google Scholar
• PonchelGMontisciMJDembriA1997Mucoadhesion of colloidal particulate systems in the gastro-intestinal tractEur J Pharm Biopharm442531
   Web of Science ®Google Scholar
• PorterCJH1997Drug delivery to the lymphatic systemCrit Rev Ther Drug Carr Syst1433393
   PubMed Web of Science ®Google Scholar
• PowersM2005Innovata emerges as first suitor in acquisition play for SkyePharmaNanobiotech News3451
   Google Scholar
• PregoCGarcíaMTorresD2005Transmucosal macromolecular drug deliveryJ Control Release1011516215588901
   PubMed Web of Science ®Google Scholar
• Quintanar-GuerreroDTamayo-EsquivelDGanem-QuintanarA2005Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheresEur J Pharm Sci26211816046105
   PubMed Web of Science ®Google Scholar
• RadtkeMMüllerRH2001Nanostructured lipid carriers: the new generation of lipid drug carriersNew Drugs24852
   Google Scholar
• RungeSMehnertWMüllerRH1996SLN (solid lipid nanoparticles), a novel formulation for the oral administration of drugsEur J Pharm Sci4Suppl 1S132
   Google Scholar
• SavocaKVDavisFFVan EsT1984Cancer therapy with chemically modified enzymes. II. The therapeutic effectiveness of arginase, and arginase modified by the covalent attachment of polyethylene glycol, on the taper liver tumor and the L5178Y murine leukemiaCancer Biochem Biophys726186488153
   PubMedGoogle Scholar
• SchubertMAMüller-GoymanCC2003Solvent injection as a new approach for manufacturing lipid nanoparticles – evaluation of the method and process parametersEur J Pharm Biopharm551253112551713
   PubMed Web of Science ®Google Scholar
• SchubertMAHarmsMMüller-GoymanCC2006Sructural investigations on lipid nanoparticles containing high amounts of lecitinEur J Pharm Sci272263616298113
   PubMed Web of Science ®Google Scholar
• SchwarzCMehnertWLucksJS1994Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilizationJ Control Release308396
   Web of Science ®Google Scholar
• SchwarzC1995Feste Lipidnanopartikel: Herstellung, Charakterisierung, Arzneistoffinkorporation und –freisetzung, Sterilisation und LyophilisationPhD thesis,Freie Universität Berlin
   Google Scholar
• ShahgaldianPDa SilvaEColemanAW2003Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parametersInt J Pharm253233812593934
   PubMed Web of Science ®Google Scholar
• SiekmannBWestesenK1992Submicron-sized parenteral carrier systems based on solid lipidsPharm Pharmacol Lett11236
   Google Scholar
• SjostromBBergenståhlB1992Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesterylacetateInt J Pharm885362
   Web of Science ®Google Scholar
• SongCLiuS2005A new healthy sunscreen system for human: Solid lipid nanoparticles as carrier for 3,4,5-trimethoxybenzoylchitin and the improvement by adding Vitamin EInt J Biol Macromolecules361169
   PubMed Web of Science ®Google Scholar
• SoutoEBWissingSABarbosaCM2004Development of a controlled release formulation based on SLN and NLC for topical clotrimazole deliveryInt J Pharm27871715158950
   PubMed Web of Science ®Google Scholar
• StosselTPMasonRJHartwigJ1972Quantitative studies on phagocytosis by polymorphonuclear leucocyctes: use of paraffin oil emulsions to measure the rate of phagocytosisJ Clin Invest51615244334720
   PubMed Web of Science ®Google Scholar
• SwartzMA2001The physiology of the lymphatic systemAdv Drug Deliv Rev5032011489331
   PubMed Web of Science ®Google Scholar
• SznitowskaMJanickiSGajewskaM2000Investigation of diazepam lipospheres based on Witepsol and lecithin for oral or rectal deliveryActa Polon Pharm57614
   PubMedGoogle Scholar
• SznitowskaMGajewskaMJanickiS2001Bioavailability of diazepam from aqueous-organic solution, submicron emulsion and solid lipid nanoparticles after rectal administration in rabbitsEur J Pharm Biopharm521596311522481
   PubMed Web of Science ®Google Scholar
• TabattKSametiMOlbrichC2004Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transferEur J Pharm Biopharm571556215018970
   PubMed Web of Science ®Google Scholar
• TobioMGrefRSánchezA1998Stealth PLA-PEG nanoparticles as protein carriers for nasal administrationPharm Res1527069523314
   PubMed Web of Science ®Google Scholar
• TobioMSánchezAVilaA2000The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administrationColloid Surf B: Biointerf1831523
   PubMed Web of Science ®Google Scholar
• TrösterSDWallisKHMüllerRH1992Correlation of surface hydrophobicity of 14C-poly(methyl methacrylate) nanoparticles to the body distributionJ Control Release2024753
   Web of Science ®Google Scholar
• ÜnerMWissingSAYenerG2005aSolid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitatePharmazie6057782
   PubMed Web of Science ®Google Scholar
• ÜnerMWissingSAYenerG2005bInvestigation of skin moisturizing effect and skin penetration of ascorbyl palmitate entrapped in solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) incorporated into hydrogelPharmazie607515
   PubMed Web of Science ®Google Scholar
• ÜnerM2006Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): Their benefits as colloidal drug carrier systemsPharmazie613758616724531
   PubMed Web of Science ®Google Scholar
• VenkateswarluVManjunathK2004Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticlesJ Control Release956273815023472
   PubMed Web of Science ®Google Scholar
• VideiraMABotelhoMFSantosAC2002Lymphatic uptake of pulmonary delivered solid lipid nanoparticlesJ Drug Target106071312683665
   PubMed Web of Science ®Google Scholar
• VilaAGillHMcCallionOAlonsoMJ2004Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating densityJ Control Release982314415262415
   PubMed Web of Science ®Google Scholar
• WangJXSunXZhangZR2002Enhanced brain targeting by synthesis of 3′,5′-dioctanoyl-5-fluoro-2′-deoxyuridine and incorporation into solid lipid nanoparticlesEur J Pharm Biopharm542859012445558
   PubMed Web of Science ®Google Scholar
• WilkinsDJMyersPA1966Studies on the relationship between the electrophoretic properties of colloids and their blood clearance and organ distribution in the ratBr J Exp Pathol47568765954081
   PubMed Web of Science ®Google Scholar
• WissingSAMüllerRH2001A novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticlesInt J Cosm Sci2323343
   PubMedGoogle Scholar
• WissingSAMüllerRH2003Cosmetic applications for solid lipid nanoparticles (SLN)Int J Pharm25465812615411
   PubMed Web of Science ®Google Scholar
• WissingSAKayserOMüllerRH2004Solid lipid nanoparticles for parenteral drug deliveryAdv Drug Deliv Rev5612577215109768
   PubMed Web of Science ®Google Scholar
• WrightJJIllumL2000Active targeting of microcapsules and microspheres to specific regionsDonbrowMMicrocapsules and nanoparticles in medicine and pharmacyThe United States of AmericaCRC Press, Inc28193
   Google Scholar
• YangSCLuLFCaiY1999aBody distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brainJ Control Release5929930710332062
   PubMed Web of Science ®Google Scholar
• YangSZhuJLuY1999bBody distribution of camptothecin solid lipid nanoparticles after oral administrationPharm Res167515710350020
   PubMed Web of Science ®Google Scholar
• YuanFDllianMFukumuraD1995Vascular permeability in human tumor xenograft: molecular size dependence and cutoff sizeJ Cancer Res5537525
   Google Scholar
• YudaTMaruyamaKIwatsuruM1996Prolongation of liposome circulation time by various derivatives of polyethyleneglycolsBiol Pharm Bull191347518913510
   PubMed Web of Science ®Google Scholar
• ZhangYZhangJ2005Surface modification of monodisperse magnetite nanoparticles for improved intracellular uptake to breast cancer cellsJ Coll Interf Sci28335257
   PubMed Web of Science ®Google Scholar
• ZimmermannEMüllerRH2001Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN™) dispersions in artificial gastrointestinal mediaEur J Pharm Biopharm522031011522487
   PubMed Web of Science ®Google Scholar
• Zur MühlenAMehnertW1998Drug release and release mechanisms of prednisolone loaded solid lipid nanoparticlesPharmazie535525
   Web of Science ®Google Scholar
• Zur MühlenASchwarzCMehnertW1998Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanismEur J Pharm Biopharm45149559704911
   PubMed Web of Science ®Google Scholar